These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39102994)

  • 1. Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement.
    Jin X; Wang S; Luo L; Yan F; He Q
    Biochem Pharmacol; 2024 Sep; 227():116463. PubMed ID: 39102994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
    Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
    J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.
    Mukherjee N; Panda CK
    Clin Breast Cancer; 2020 Oct; 20(5):361-370. PubMed ID: 32416986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the WNT Signaling Pathway in Cancer Therapeutics.
    Tai D; Wells K; Arcaroli J; Vanderbilt C; Aisner DL; Messersmith WA; Lieu CH
    Oncologist; 2015 Oct; 20(10):1189-98. PubMed ID: 26306903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
    Yan M; Li G; An J
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
    Vilchez V; Turcios L; Marti F; Gedaly R
    World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
    White BD; Chien AJ; Dawson DW
    Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of targeting Wnt/β-catenin in colon cancer.
    Sebio A; Kahn M; Lenz HJ
    Expert Opin Ther Targets; 2014 Jun; 18(6):611-5. PubMed ID: 24702624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
    Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
    Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in targeting the WNT/β-catenin signaling pathway in cancer.
    Chatterjee A; Paul S; Bisht B; Bhattacharya S; Sivasubramaniam S; Paul MK
    Drug Discov Today; 2022 Jan; 27(1):82-101. PubMed ID: 34252612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of β-catenin activity and function in cancer: therapeutic opportunities.
    Shang S; Hua F; Hu ZW
    Oncotarget; 2017 May; 8(20):33972-33989. PubMed ID: 28430641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
    Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
    Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the role of Wnt biology in cancer.
    Mirabelli CK; Nusse R; Tuveson DA; Williams BO
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.